Genetic testing company 23andMe Inc. has raised around $82.5 million in new funding, according to a filing with the U.S. Securities and Exchange Commission. The Series F round was led by Sequoia Capital and NewView Capital and was undersubscribed, according to a report Monday by Bloomberg, with 23andMe having attempted to raise $85 million. A spokesperson for …
The post Genetic testing company 23andMe raises $82.5M from Sequoia and NewView Capital appeared first on World Consulting Group.